# A Prospective Evaluation of Microwave Ablation (MWA) in the Treatment of Relapsed Graves' Disease

> **NCT06506149** · NA · RECRUITING · sponsor: **The University of Hong Kong** · enrollment: 25 (estimated)

## Conditions studied

- Graves Disease
- Minimally Invasive Treatment
- Ablation Treatment

## Interventions

- **DEVICE:** Microwave ablation(MWA) device

## Key facts

- **NCT ID:** NCT06506149
- **Lead sponsor:** The University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-07-04
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-06-30
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2024-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06506149

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06506149, "A Prospective Evaluation of Microwave Ablation (MWA) in the Treatment of Relapsed Graves' Disease". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06506149. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*